International Consolidated Airlines Group SA
Change company Symbol lookup
Select an option...
ICAGY International Consolidated Airlines Group SA
$NQUSS451020JPYT Nasdaq US Small Cap Food Producers T
LULU Lululemon Athletica Inc
AICAF Air China Ltd
OBMP OncBioMune Pharmaceuticals Inc
AVNW Aviat Networks Inc
AMPY Amplify Energy Corp
JEPI JPMorgan Equity Premium Income ETF
ABBV Abbvie Inc
VOLAF Volvo AB
Go

Industrials : Airlines | Large Cap Value
Based in United Kingdom
Company profile

International Consolidated Airlines Group, S.A. is an airline company that holds the interests in airline and ancillary operations. Its segments include British Airways, Iberia, Vueling, Aer Lingus and Other Group companies. It combines the airlines in the United Kingdom, Spain and Ireland. It has approximately 573 aircrafts to over 268 destinations. The Company operates various aircraft fleet services, including Airbus A318, Airbus A319, Airbus A340-600, Boeing 787-800, Embraer E190 and Boeing 777-200, among others. The Company, through its subsidiaries, is engaged in providing airline marketing, airline operations, insurance, aircraft maintenance, storage and custody services, air freight operations and cargo transport services. The Company offers its services in cities, including London, Madrid, Barcelona, Rome and Dublin. The Company's brands include British Airways, Iberia, LEVEL, Vueling, Aer Lingus, IAG Cargo and Avios.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$5.80
Day's Change
0.0401 (0.70%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.84
Day's Low
5.76
Volume
(Light)
Volume:
265,347

10-day average volume:
340,747
265,347

Ocugen's stock triples on massive volume after institutional investors buy stock at a 27% premium

1:05 pm ET February 8, 2021 (MarketWatch)
Print

Shares of Ocugen Inc. (OCGN) more than tripled on massive volume Monday, after the biopharmaceutical company working on a treatment for blindness and a potential COVID-19 vaccine announced a direct offering of stock to institutional investors at a 27% premium. The stock led the Nasdaq's gainers list with a 238.9% rally in afternoon trading, and was the most actively traded on the Nasdaq with volume of 504.7 million shares, which compares with the full-day average of about 63.1 million shares over the past 30 days. The company said earlier that it entered into agreements with health care-focused institutional investors for the sale of 3 million shares of common stock at $7.65 a share, which was well above Friday's closing price of $5.25. The stock offering comes about a week after the company entered into an agreement with India-based Bharat Biotech to develop and commercialize Bharat's Covaxin, an "advanced stage whole-virion inactivated COVID-19 vaccine candidate" for the U.S. market. Covaxin has been granted permission by India's Central Licensing Authority for restricted use in emergency situations. Ocugen's stock, which was trading below $1 as recently as Dec. 22, has skyrocketed 6,255.2% over the past three months, while the iShares Nasdaq Biotechnology ETF (IBB) has rallied 24.8% and the S&P 500 has gained 11.1%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

February 08, 2021 13:05 ET (18:05 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.